4//SEC Filing
O'Brien Stephanie Monaghan 4
Accession 0001127602-22-000497
CIK 0001492422other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:41 PM ET
Size
6.8 KB
Accession
0001127602-22-000497
Insider Transaction Report
Form 4
O'Brien Stephanie Monaghan
Director
Transactions
- Award
Common Stock
2022-01-01+4,230→ 4,230 total - Award
Stock Option (Right to Buy)
2022-01-01+8,554→ 8,554 totalExercise: $47.28Exp: 2029-12-31→ Common Stock (8,554 underlying)
Footnotes (2)
- [F1]This represents a restricted stock unit grant made on 1/1/2022 that fully vest on the first anniversary of the date of grant, subject to continued service as a director.
- [F2]This represents a non-qualified stock option grant made on 1/1/2022 that vests quarterly over 1 year from the date of grant, subject to continued service as a director, and expires seven years from the date of grant.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720907
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:41 PM ET
- Size
- 6.8 KB